Image

Global Immunoassay Reagents and Devices Market - Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Apr 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Healthcare
  • Upcoming Report
  • Apr 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Immunoassay Reagents and Devices Market, By Product (Reagents and Kits, Analyzers), Platform (Chemiluminescence Immunoassays, Fluorescence Immunoassays, Enzyme Immunoassay, Radioimmunoassays and Others), Technique (Enzyme-Linked Immunosorbent Assays, Rapid Tests, Enzyme-Linked Immunospot, Western Blotting, Immuno-PCR and Other Techniques), Specimen Type (Blood, Urine, Saliva and Others), Application (Infectious Diseases, Oncology And Endocrinology, Bone and Mineral Disorders, Cardiology, Hematology and Blood Screening, Autoimmune Disorders, Toxicology, Neonatal Screening and Other Applications), End User (Hospitals, Clinical Laboratories, Pharmaceutical And Biotechnology Companies, Blood Banks, Research and Academic Laboratories and Others)-Industry Trends and Forecast to 2029

Immunoassay Reagents and Devices Market

Market Analysis and Size

Immunoassay has become a standard laboratory technique for determining the concentration of various analytes. Almost all diagnostic laboratories, academic and research institutes, hospital diagnostic centres, and other possible end users have embraced immunoassay systems. Multiplex immunoassays have broadened the uses of immunoassay systems in a variety of industries, including pharmaceutical firms, biotechnology and life science companies, food and beverage companies, environmental monitoring, and so on.

Reagents and kits segment is expected to dominate in the immunoassay reagents and devices market due to its increased use in drug development as well as illness detection, the 2021. Data Bridge Market Research analyses that the immunoassay reagents and devices market was valued ay USD 4.22 trillion in 2021 and is further estimated to reach USD 6.43 trillion by 2029, and is expected to grow at a CAGR of 5.4% during the forecast period of 2022 to 2029.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Trillion, Volumes in Units, Pricing in USD

Segments Covered

Product (Reagents and Kits, Analyzers), Platform (Chemiluminescence Immunoassays, Fluorescence Immunoassays, Enzyme Immunoassay, Radioimmunoassays and Others), Technique (Enzyme-Linked Immunosorbent Assays, Rapid Tests, Enzyme-Linked Immunospot, Western Blotting, Immuno-PCR and Other Techniques), Specimen Type (Blood, Urine, Saliva and Others), Application (Infectious Diseases, Oncology And Endocrinology, Bone and Mineral Disorders, Cardiology, Hematology and Blood Screening, Autoimmune Disorders, Toxicology, Neonatal Screening and Other Applications), End User (Hospitals, Clinical Laboratories, Pharmaceutical And Biotechnology Companies, Blood Banks, Research and Academic Laboratories and Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

F. Hoffmann-La Roche Ltd (Switzerland), Siemens (Germany), Randox Laboratories Ltd. (UK), Abbott (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Beckman Coulter, Inc. (US), bioMérieux SA (France), Thermo Fisher Scientific (US), BD (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (US), DiaSorin S.p.A (Italy), Ortho Clinical Diagnostics (US), QIAGEN (Germany), Quidel Corporation (US), BioCheck, Inc. (US), Bio-Techne (US), PerkinElmer Inc. (US), Agilent Technologies, Inc. (US), Luminex Corporation (US), MESO SCALE DIAGNOSTICS, LLC (US).

Market Opportunities

  • The prevalence of chronic and infectious diseases is increasing.
  • The rising utilisation of immunoassay reagents and devices.
  • The advancement of immunoassay reagents and devices.

Market Definition

Immunoassays are tests that are used in laboratories to detect specific substances. It all comes down to the antibody's capacity to bind to the specific structure of the molecule (antigen) that is present in the sample. Antibodies are created in the body as a reaction to the presence of antigen.

Immunoassay Reagents and Devices Market Dynamics                      

Drivers

Major factors that are expected to boost the growth of the immunoassay reagents and devices market in the forecast period are as follows:

  • Rise in the prevalence of chronic and infectious diseases

The chronic diseases including diabetes, heart disease, and cancer are on the rise all across the world. Infectious diseases such as SARS-CoV2 (COVID-19), dengue fever, Hepatitis B, C, HIV, Malaria, Tuberculosis, and others are spreading at an alarming rate. Immunoassay diagnosis has become a critical component of many disorders' diagnosis which will further accelerate the market growth.

  • Growing usage of immunoassays in oncology

According to the American Cancer Society, cancer claimed the lives of about 606,880 people in the United States in 2019. As a result, the need for immunoassay reagents and devices is increasing as the number of cancer patients diagnosed rises is further anticipated to propel the growth of the market.

  • Immunoassays for COVID-19 and other viral diagnostics

The use of immunoassay devices is crucial in preventing the spread of COVID-19. In the absence of a vaccine or medication, the only effective strategy to limit and manage the spread of illnesses and potential causalities is to diagnose them which will further contribute the market growth.

Opportunities

In addition, the significance of companion diagnostics in the immunoassay reagents and devices are further estimated to provide potential opportunities for the growth of the immunoassay reagents and devices market in the coming years.

Restraints/Challenges

 On the other hand, the strict demands for the approval of immunoassay instruments and consumables and technical hurdles of immunoassay kits is further projected to impede the growth of the immunoassay reagents and devices market in the targeted period. However, the lack of skilled professionals and unsuitable reimbursement scenario might further challenge the growth of the immunoassay reagents and devices market in the near future.

This immunoassay reagents and devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the immunoassay reagents and devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 Impact on Immunoassay Reagents and Devices Market

The COVID-19 had a positive impact on the immunoassay reagents and devices market. The immunoassay reagents and devices is crucial in preventing COVID-19 from spreading. In the absence of a vaccine or medication, the only effective strategy to limit and manage the spread of illnesses and potential causalities is to diagnose them. Rapid testing have proven to be an effective, quick, and easy molecular test for COVID-19 surveillance on a broad scale.

Recent Development

  • In January, 2021, for the asymptomatic diagnosis of the SARS-CoV-2 virus, Abbott's Panbio COVID-19 Ag Rapid Test Device got the CE Mark. It also has self-swabbing capabilities.

Global Immunoassay Reagents and Devices Market Scope and Market Size

The immunoassay reagents and devices market is segmented on the basis of product, platform, technique, specimen type, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Reagents and Kits
  • Analyzers

On the basis of product, the immunoassay reagents and devices market is segmented into reagents and kits and analyzers.

Platform                                                                                               

  • Chemiluminescence Immunoassays
  • Fluorescence Immunoassays
  • Enzyme Immunoassay
  • Radioimmunoassays
  • Others

On the basis platform, the immunoassay reagents and devices market is segmented into chemiluminescence immunoassays, fluorescence immunoassays, enzyme immunoassay, radioimmunoassays and others.

Technique

  • Enzyme-Linked Immunosorbent Assays
  • Rapid Tests
  • Enzyme-Linked Immunospot
  • Western Blotting
  • Immuno-PCR
  • Other Techniques

On the basis of technique, the immunoassay reagents and devices market is segmented into enzyme-linked immunosorbent assays, rapid tests, enzyme-linked immunospot, western blotting, immuno-PCR and other techniques.

Specimen Type

  • Blood
  • Urine
  • Saliva
  • Others

On the basis of specimen type, the immunoassay reagents and devices market is segmented into saliva, urine, blood and others.

Application

  • Infectious Diseases
  • Oncology And Endocrinology
  • Bone and Mineral Disorders
  • Cardiology
  • Hematology and Blood Screening
  • Autoimmune Disorders
  • Toxicology
  • Neonatal Screening
  • Other Applications

On the basis of application, the immunoassay reagents and devices market is segmented into infectious diseases, oncology and endocrinology, bone and mineral disorders, cardiology, hematology and blood screening, autoimmune disorders, toxicology, neonatal screening and other applications.

End User

  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical And Biotechnology Companies
  • Blood Banks
  • Research and Academic Laboratories
  • Others

On the basis of end user, the immunoassay reagents and devices market is segmented into hospitals, clinical laboratories, pharmaceutical and biotechnology companies, blood banks, research and academic laboratories and others.

Immunoassay Reagents and Devices Market Regional Analysis/Insights

The immunoassay reagents and devices market is analysed and market size insights and trends are provided by country, product, platform, technique, specimen type, application and end user as referenced above.

The countries covered in the immunoassay reagents and devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the immunoassay reagents and devices market due to the rise in the prevalence rates of chronic disorders and infectious diseases. Furthermore, the growing number of elderly population and well-established healthcare infrastructure will boost the growth of the immunoassay reagents and devices market in the region during the forecast period.

Asia-Pacific is projected to observe significant of the growth during the forecast period of 2022 to 2029 in the immunoassay reagents and devices market due to the occurrence of the highest number of immunoassay reagents and devices providers.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The immunoassay reagents and devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for immunoassay reagents and devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the immunoassay reagents and devices market. The data is available for historic period 2010-2020.

Competitive Landscape and Immunoassay Reagents and Devices Market Share Analysis

The immunoassay reagents and devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to immunoassay reagents and devices market.

Some of the major players operating in the immunoassay reagents and devices market are

  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Siemens (Germany)
  • Randox Laboratories Ltd. (UK)
  • Abbott (US)
  • Bio-Rad Laboratories, Inc. (US)
  • Merck KGaA (Germany)
  • Beckman Coulter, Inc. (US)
  • bioMérieux SA (France)
  • Thermo Fisher Scientific (US)
  • BD (US)
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (US)
  • DiaSorin S.p.A (Italy)
  • Ortho Clinical Diagnostics (US)
  • QIAGEN (Germany)
  • Quidel Corporation (US)
  • BioCheck, Inc. (US)
  • Bio-Techne (US)
  • PerkinElmer Inc. (US)
  • Agilent Technologies, Inc. (US)
  • Luminex Corporation (US)
  • MESO SCALE DIAGNOSTICS, LLC (US)


SKU-
Why Choose Us


Frequently Asked Questions

The market value for Immunoassay Reagents and Devices Market is expected USD 6.43 trillion by 2029.
The Immunoassay Reagents and Devices Market is to grow at a CAGR of 5.4% during the forecast by 2029.
On the basis of application, the Immunoassay Reagents and Devices Market is segmented into Infectious Diseases, Oncology And Endocrinology, Bone and Mineral Disorders, Cardiology, Hematology and Blood Screening, Autoimmune Disorders, Toxicology, Neonatal Screening and Other Applications.
On the basis of product, the Immunoassay Reagents and Devices Market is segmented into Reagents and Kits, Analyzers.